优化儿童多发性硬化症的治疗方法
Nail Benallegue1,2, Fabien Rollot3,4,5,6, David-Axel Laplaud2,7
1Department of Pediatric Neurology, CHU Angers, Univ Angers, Angers, France.
Expert review of neurotherapeutics
|May 30, 2025
概括
由于炎症加剧,建议对儿科发病多发性硬化症 (POMS) 进行高效疗法. 使用这些先进疗法的早期治疗可以改善POMS儿童的治疗结果和生活质量.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 儿科发病多发性硬化症 (POMS) 与成人多发性硬化症相比,具有独特的临床特征.
- POMS的特点是炎症增加,复发率更高,病变负担更大.
- 认知障碍和大脑生长障碍在POMS中更为明显,尽管早期的身体残疾较小.
研究的目的:
- 审查POMS目前的治疗策略.
- 在POMS中评估各种疗法的安全性和有效性.
- 为优化POMS管理提供专家意见.
主要方法:
- 在MEDLINE和谷歌学者 (2000-2024) 的文献搜索.
- 观察性研究和随机对照试验的审查.
- 对POMS治疗的安全性和疗效数据的分析.
主要成果:
- 高效疗法 (HETs) 如fingolimod,natalizumab和抗CD20药物显示出优越的疾病控制和残疾预防.
- 建议早期启动HET,以获得POMS中更好的结果和生活质量.
- 低/中等效率的疗法最适合于轻度POMS病例.
结论:
- HETs代表了对POMS的有希望的护理标准,解决了其高度的神经炎症活动.
- 需要进一步研究长期安全性,预后标志物和降级策略.
- 未来的研究应侧重于平衡疾病控制与不良影响,考虑到老化和个体患者的发展轨迹.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


